Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J van Veen

Showing results (41-50 of 67) with videos related to

Pageof 7
Sort By:
The Cochrane Database of Systematic Reviews|July 10, 2009
Interventions for erythema nodosum leprosumNatasja H J Van Veen, Diana N J Lockwood, Wim H van Brakel, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|October 1, 2011
Protamine reversal of low molecular weight heparin: clinically effective?Joost J van Veen, Rhona M Maclean, Kingsley K Hampton, et al.
International Journal of Integrated Care|March 18, 2015
An instrument for broadened risk assessment in antenatal health care including non-medical issuesAmber A Vos, Mieke J van Veen, Erwin Birnie, et al.
Leprosy Review|March 24, 2010
Interventions for erythema nodosum leprosum. A Cochrane reviewNatasja H J Van Veen, Diana N J Lockwood, Wim H Van Brakel, et al.
Journal of Thrombosis and Haemostasis : JTH|August 1, 2007
Antiviral therapy for chronic hepatitis C in patients with inherited bleeding disorders: an international, multicenter cohort studyD Posthouwer, T T Yee, M Makris, et al.
International Journal of Laboratory Hematology|October 1, 2010
The investigation of a prolonged APTT with specific clotting factor assays is unnecessary if an APTT with Actin FS is normalA Bowyer, J Smith, A M Woolley, et al.
Clinical and Laboratory Haematology|January 24, 2004
Diagnosis of plasma cell leukaemia: findings of the UK NEQAS for Leucocyte Immunophenotyping schemeJ J van Veen, J T Reilly, S J Richards, et al.
British Journal of Haematology|March 9, 2022
Von Willebrand factor assays in patients with acquired immune thrombotic thrombocytopenia purpura treated with caplacizumabAnnette Bowyer, Paula Brown, Barbara Hopkins, et al.
BMJ Open|November 5, 2025
Implementation strategy for an antibiotic stewardship bundle to promote optimal treatment choices in neonates with suspected early-onset sepsis (Protect-Neo): a study protocol for a multicentre, prospective interrupted time series and before-after studyLiesanne E J van Veen, Gerdien A Tramper-Stranders, Niek B Achten, et al.
Disability and Rehabilitation|August 17, 2010
Evaluation of activity limitation and social participation, and the effects of reconstructive surgery in people with disability due to leprosy: a prospective cohort studyNatasja H J van Veen, Dinabandhu A Hemo, Robert L Bowers, et al.
Pageof 7

Showing results (41-50 of 67) with videos related to

Sort By:
Pageof 7
The Cochrane Database of Systematic Reviews|July 10, 2009
Interventions for erythema nodosum leprosumNatasja H J Van Veen, Diana N J Lockwood, Wim H van Brakel, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|October 1, 2011
Protamine reversal of low molecular weight heparin: clinically effective?Joost J van Veen, Rhona M Maclean, Kingsley K Hampton, et al.
International Journal of Integrated Care|March 18, 2015
An instrument for broadened risk assessment in antenatal health care including non-medical issuesAmber A Vos, Mieke J van Veen, Erwin Birnie, et al.
Leprosy Review|March 24, 2010
Interventions for erythema nodosum leprosum. A Cochrane reviewNatasja H J Van Veen, Diana N J Lockwood, Wim H Van Brakel, et al.
Journal of Thrombosis and Haemostasis : JTH|August 1, 2007
Antiviral therapy for chronic hepatitis C in patients with inherited bleeding disorders: an international, multicenter cohort studyD Posthouwer, T T Yee, M Makris, et al.
International Journal of Laboratory Hematology|October 1, 2010
The investigation of a prolonged APTT with specific clotting factor assays is unnecessary if an APTT with Actin FS is normalA Bowyer, J Smith, A M Woolley, et al.
Clinical and Laboratory Haematology|January 24, 2004
Diagnosis of plasma cell leukaemia: findings of the UK NEQAS for Leucocyte Immunophenotyping schemeJ J van Veen, J T Reilly, S J Richards, et al.
British Journal of Haematology|March 9, 2022
Von Willebrand factor assays in patients with acquired immune thrombotic thrombocytopenia purpura treated with caplacizumabAnnette Bowyer, Paula Brown, Barbara Hopkins, et al.
BMJ Open|November 5, 2025
Implementation strategy for an antibiotic stewardship bundle to promote optimal treatment choices in neonates with suspected early-onset sepsis (Protect-Neo): a study protocol for a multicentre, prospective interrupted time series and before-after studyLiesanne E J van Veen, Gerdien A Tramper-Stranders, Niek B Achten, et al.
Disability and Rehabilitation|August 17, 2010
Evaluation of activity limitation and social participation, and the effects of reconstructive surgery in people with disability due to leprosy: a prospective cohort studyNatasja H J van Veen, Dinabandhu A Hemo, Robert L Bowers, et al.
Pageof 7